Search
Now showing items 11-20 of 56
Association of high serum levels of growth factors with good outcome in ischemic stroke: a multicenter study
(Springer Nature, 2019-11-25)
[Abstract] The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1α with the functional outcome and reduction of lesion volume in ischemic stroke patients. In ...
Delayed neurological improvement after full endovascular reperfusion in acute anterior circulation ischemic stroke
(American Heart Association, 2021-05-20)
[Abstract] Background and purpose: We aimed to determine the prevalence and predictors of delayed neurological improvement (DNI) after complete endovascular reperfusion in anterior circulation acute ischemic stroke ...
Cav-1 protein levels in serum and infarcted brain correlate with hemorrhagic volume in a mouse model of thromboembolic stroke, independently of rt-PA administration
(Springer Nature, 2022-01-05)
[Abstract] Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for acute ischemic stroke. However, its administration is still limited due to the associated ...
Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology
(Sage, 2024-10-28)
[Abstract]
Background: A deep knowledge of the healthcare system and the organization of neurology departments is important for planning and optimizing changes to facilitate the successful implementation of anti-amyloid ...
Stroke care during the COVID-19 outbreak in Spain: the experience of spanish stroke units
(BMJ, 2020-12-04)
[Abstract]
Background and purpose: Spain has been heavily affected by COVID-19. Reallocation of resources for managing the outbreak might have caused a disruption in stroke care. This study analyses the impact on stroke ...
Worse outcome in stroke patients treated with rt-PA without early reperfusion: associated factors
(Springer Nature, 2017-11-07)
[Abstract] Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients the possible risk of worse clinical outcome after ...
Documento de consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV): ventana de oportunidad: prevención del riesgo vascular en la mujer: resultados adversos del embarazo y riesgo de enfermedad vascular
(Sociedad Española de Ginecología y Obstetricia (SEGO), 2023)
[Resumen] Este documento resume la evidencia que existe entre los resultados adversos del embarazo (RAE), tales como son los trastornos hipertensivos,
el parto pretérmino, la diabetes gestacional, los defectos en el ...
Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021
(Elsevier en nombre de la Sociedad Española de Nefrología, 2022-06-10)
[Resumen] Presentamos la adaptación española de las Guías Europeas de Prevención Cardiovascular 2021. En esta actualización además del abordaje individual, se pone mucho más énfasis en las políticas sanitarias como estrategia ...
Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial
(American Medical Association, 2023-06-20)
[Abstract] Importance: ApTOLL is a TLR4 antagonist with proven preclinical neuroprotective effect and a safe profile in healthy volunteers.
Objective: To assess the safety and efficacy of ApTOLL in combination with ...
Estudio de la situación actual del Teleictus en España
(Elsevier, 2023-08-07)
[Resumen] Introducción. En los últimos años se ha establecido el uso del Teleictus como una herramienta fundamental para extender la atención a los pacientes con ictus agudo hasta hospitales que no disponen de neurólogos ...
